Infertility, Female Clinical Trial
Official title:
The Role of Intracytoplasmic Sperm Injection in Non-male Factor Infertility in Maternal Age Above 39
The use of Intracytoplasmic sperm injection (ICSI) has increased in the last decades regardless of the cause of infertility. Despite the increased use there is no clear evidence that ICIS is more effective than conventional in vitro fertilization (IVF) for non-male factor infertility. The investigators therefore aim to perform a prospective randomized controlled study to compare between ICSI and conventional IVF in women between 39 to 44 years of age with non-male factor infertility.
ICSI is a method used in IVF in which a single sperm is injected directly into an oocyte.
Originally ICSI was developed as a method for the treatment for couples with severe male
factor infertility. In the last decades the use of ICSI has increased dramatically,
especially for non-male factor infertility. In certain fertility clinics in the world ICSI is
conducted in 100% of IVF cycles.
Despite the increased use of ICSI, there is no clear evidence that ICIS is more effective
than conventional IVF for non-male factor infertility. There are currently few randomized
controlled studies that compared the two modalities in the case of non-male factor
infertility. In a randomized controlled trial that included 415 couples with non-male factor
infertility and women younger than 37 years of age, conventional IVF was associated with
better fertilization and implantation rates than ICSI but with comparable live birth rates.
In addition, studies have not shown an advantage for ICSI over conventional IVF in the case
of unexplained infertility, low oocyte yield or routine use to decrease the incidence of
fertilization failure.
The proportion of women after the age of 35 undergoing IVF is constantly on the rise. Oocytes
retrieved from older women are often of lower quality then oocytes retrieved from younger
women. It is believed that due to the lower quality the fertilization rate is decreased in
this population. However a recently published retrospective study including 745 women did not
show an advantage for ICSI over conventional IVF. Contrary to what is believed, the
conventional IVF group had a higher number of zygotes formed, more cycles with embryos
transferred at the blastocyst stage and more cycles where embryos were available for
cryopreservation.
The investigators therefore aim to perform a prospective randomized controlled study to
compare between ICSI and conventional IVF in women between 39 to 44 years of age with
non-male factor infertility. Male-factor infertility will be diagnosed according to the
accepted semen analysis values included a semen concentration of 200 million/mL, progressive
motility of 40% and a strict morphology of 4%. Patients will undergo standard clinical and
hormonal investigation as usual for IVF. The treatment protocol will be in accordance with
the decision of the attending physician, regardless of the research. Randomization will be
between the ovaries of each patient. Following an informed consent a computer based
randomization will allocate either ICSI or conventional IVF for each ovary so that for each
study participant oocyte from one ovary will be randomly allocated to insemination by ICSI
and the oocytes from the other ovary will be allocated to insemination by conventional IVF.
As is customary in our IVF unit, 24, 72 and 96 hours after oocyte retrieval, the embryos will
by studied by an embryologist for the number of cells and embryo quality.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05969574 -
Is Decreased Ovarian Reserve Related to an Increased Number of Previous Early Miscarriages?
|
||
Recruiting |
NCT05358483 -
PROspective Study of Mothers' and Infants' Social and Epidemiologic Determinants of Health
|
||
Recruiting |
NCT05969795 -
Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support
|
Phase 1 | |
Recruiting |
NCT06051201 -
Innovation for Small-scale Experiments: ReceptIVFity Test
|
N/A | |
Completed |
NCT03177538 -
Corifollitropin Alfa Combined With Menotropin Versus Follitropin and Lutropin Alfa in Expected Suboptimal Responders
|
Phase 4 | |
Completed |
NCT03638856 -
Comparing Effectiveness of Oral Misoprostal for Cervical Priming in Hysteroscopy
|
N/A | |
Completed |
NCT04052464 -
The Study of the Implantation Window From Endometrial Biopsy With Gene Expression Methods
|
||
Withdrawn |
NCT04753736 -
Immunophenotypage of RIF and RM Patients and Intrauterine Administration of PBMC
|
N/A | |
Completed |
NCT03349905 -
Deferred Versus Fresh Embryo Transfers
|
N/A | |
Completed |
NCT05076981 -
Progesterone Levels During Ovulation and Luteal Phase
|
||
Completed |
NCT04096027 -
Cabergoline Before or After Oocyte Collection for Follicular Resolution
|
Phase 4 | |
Recruiting |
NCT05980091 -
Optimal Timing of Euploid Day 6 Blastocyst Transfer in Frozen HRT Cycles, Day 6 or Day 7 of Progesterone Administration.
|
Phase 1 | |
Terminated |
NCT01933633 -
Improved Fertility After Exercise in Overweight/Obese Women
|
N/A | |
Terminated |
NCT01202643 -
Effect of Colony Stimulating Factor on Poor Endometrial Development During IVF
|
Phase 1/Phase 2 | |
Completed |
NCT01202656 -
Effect of Colony Stimulating Factor on Implantation and Pregnancy Rates Following IVF (in Vitro Fertilization)
|
Phase 1/Phase 2 | |
Completed |
NCT01408615 -
A Post Marketing Observational Study of the Safety and Efficacy of Elonva (Corifollitropin Alfa) in General Practice (P08165)
|
||
Enrolling by invitation |
NCT05698550 -
The Role of Erzhi Tiangui Formula in Expected POR Women Undergoing IVF-ET
|
Phase 3 | |
Not yet recruiting |
NCT03910582 -
Personalized FET in RIF Patients With Displaced Dating
|
N/A | |
Completed |
NCT05440019 -
Evaluation of the Safety and Usability of the M3T Fertigo System and Its Calibration
|
||
Completed |
NCT05130125 -
Retrospective Cohort Observational Study to Evaluate the Effectiveness and Safety of Fresh or Frozen Embryo Transfer
|